Use of nicotine or its derivatives in a drug for treating neurological disease, in particular Parkinson's disease
US6911475B1 · kind B1 · utility
33Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2000 |
| Grant date | Jun 28, 2005 |
| Priority date | — |
| Expiry date | Sep 1, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns the use of nicotine or a derivative thereof for producing a drug for continuous or progressive administration of 0.2 mg to 5 mg per day per kilogram of body weight in man, said drug being administered simultaneously with L-DOPA in a dose at least 30% lower than the effective dose when L-DOPA is administered alone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.